Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March

Ogkologos - 14 Μαρτίου, 2025

New on NCI’s Websites for March 2025

Ogkologos - 13 Μαρτίου, 2025

FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT...

Ogkologos - 13 Μαρτίου, 2025

Breast Cancer Death Rates Will Rise in Elderly EU Patients but...

Ogkologos - 12 Μαρτίου, 2025

First Mature Estimation of Median OS for Selpercatinib in Patients with...

Ogkologos - 12 Μαρτίου, 2025

Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer

Ogkologos - 11 Μαρτίου, 2025

Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of...

Ogkologos - 11 Μαρτίου, 2025

Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk...

Ogkologos - 10 Μαρτίου, 2025

TACE-Based Treatment Combinations Effective Against Intermediate-Stage Liver Cancer

Ogkologos - 7 Μαρτίου, 2025

FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic HR-positive, HER2-low or...

Ogkologos - 6 Μαρτίου, 2025

1...555657...440 Σελίδα 56 από 440

MOST POPULAR

Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...

3 Ιουλίου, 2024

Significant Interaction Between a Chemotherapy Benefit and Menopausal Status Found in...

7 Δεκεμβρίου, 2021

2020 round-up: Our biggest cancer stories of the year

20 Δεκεμβρίου, 2020

Utility of Serial ctDNA in Guiding Anti-EGFR Rechallenge in Metastatic Colorectal...

7 Σεπτεμβρίου, 2022

Φόρτωση περισσοτέρων

ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March

New on NCI’s Websites for March 2025

FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT...

Breast Cancer Death Rates Will Rise in Elderly EU Patients but...

First Mature Estimation of Median OS for Selpercatinib in Patients with...

Combination Therapy for Metastatic Prostate Cancer Helps Some Men Live Longer

Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of...

Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk...

TACE-Based Treatment Combinations Effective Against Intermediate-Stage Liver Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic HR-positive, HER2-low or...

MOST POPULAR

Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...

Significant Interaction Between a Chemotherapy Benefit and Menopausal Status Found in...

2020 round-up: Our biggest cancer stories of the year

Utility of Serial ctDNA in Guiding Anti-EGFR Rechallenge in Metastatic Colorectal...

HOT NEWS

Record Impact Factor for Annals of Oncology Highlights Growing Influence of...

Trastuzumab Deruxtecan Prolongs PFS After Endocrine-Based Therapy in Patients with HR-positive,...

Metastatic Colorectal Cancer May Spread Early in the Disease, Study Finds

Καρκίνος οισοφάγου

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ